Palatin Technologies
PTN
#10836
Rank
C$21.83 M
Marketcap
C$12.26
Share price
-4.55%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$3.75 Million

According to Palatin Technologies's latest financial reports the company's total liabilities are C$3.75 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30C$10.94 M-26.25%
2024-06-30C$14.84 M-43.71%
2023-06-30C$26.36 M3.41%
2022-06-30C$25.49 M16.58%
2021-06-30C$21.86 M230.05%
2020-06-30C$6.62 M20.91%
2019-06-30C$5.47 M-65.42%
2018-06-30C$15.84 M-80.32%
2017-06-30C$80.53 M118.51%
2016-06-30C$36.85 M71.05%
2015-06-30C$21.54 M628.92%
2014-06-30C$2.95 M34.16%
2013-06-30C$2.2 M-39.03%
2012-06-30C$3.61 M25.79%
2011-06-30C$2.87 M-11.62%
2010-06-30C$3.25 M-71.38%
2009-06-30C$11.35 M-11.3%
2008-06-30C$12.8 M-50.18%
2007-06-30C$25.7 M6.45%
2006-06-30C$24.14 M-25.02%
2005-06-30C$32.2 M187.43%
2004-06-30C$11.2 M104.64%
2003-06-30C$5.47 M-1.63%
2002-06-30C$5.56 M57.77%
2001-06-30C$3.52 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$165.47 B 4,408,168.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$93.31 B 2,485,717.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$2.37 B 63,143.79%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
C$4.5 M 20.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$1.73 B 46,164.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$1.27 B 33,957.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
C$3.73 M-0.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.60 B 16,109.89%๐Ÿ‡บ๐Ÿ‡ธ USA